^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

NZV930

i
Other names: NZV930, SRF373
Associations
Trials
Company:
Coherus Biosci, Novartis
Drug class:
CD73 inhibitor
Associations
Trials